STAT Plus: Roche is fined by Romania for thwarting competition to its cancer medicines
SEBASTIEN BOZON/AFP/GETTY IMAGES
Roche allegedly monopolized markets for Rituxan and Herceptin by undercutting rival bidders in auctions held to supply a national program for cancer drugs.
No hay comentarios:
Publicar un comentario